Dual-Use Chemical and Life Science Research of Potential Concern

  • Chapter
  • First Online:
Toxin and Bioregulator Weapons

Part of the book series: Global Issues ((GLOISS))

  • 179 Accesses

Abstract

This chapter explores what is happening to the chemical, life, and associated sciences in the first decades of the twenty-first century. It is concluded that a rapid set of advances in converging disciplines is leading to a huge increase in our capabilities to understand the physiology of living organisms and thus our ability to modify such systems. It is then suggested that this is a ‘game changer’ for the potential development of novel toxin and bioregulator weapons—previously weaponeers were only able to modify known agents, but now they will be able to design an ever-increasing number of novel agents that target particular points in victims’ nervous, immune, and hormonal systems. The chapter then demonstrates that toxicology has been part of this massive advance in the life sciences through an examination of recent work on botulinum toxin, staphylococcal enterotoxins, bioregulators, and advances in neuroimmunology. In conclusion it is argued that the advances taking place are probably soon going to give us a coherent and detailed understanding of how toxin and bioregulators act on living systems. Although such advances have important medical and other beneficial applications, the dangers for malign use must also be recognised and addressed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
GBP 19.95
Price includes VAT (United Kingdom)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
GBP 87.50
Price includes VAT (United Kingdom)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
GBP 109.99
Price includes VAT (United Kingdom)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
GBP 109.99
Price includes VAT (United Kingdom)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    Meselson, M. (2000) Averting the hostile exploitation of biotechnology. The Chemical and Biological Weapons Conventions Bulletin, 48, 16–19. p. 16.

  2. 2.

    Trapp, R. (2018) Convergence of Chemistry and Biology, and Nanotechnology, Chapter 7 in M. Crowley, et al. (Eds.) Preventing Chemical Weapon; Arms Control and Disarmament as the Sciences Converge. Royal Society of Chemistry, London. p. 195.

  3. 3.

    Herzig, V. et al (2020) Animal toxins—Nature’s evolutionary-refined toolkit for basic research and drug discovery. Biochemical Pharmacology, 181, 114096. https://doi.org/10.1016/j.bcp.2020.114096. p. 2.

  4. 4.

    Urbina, F. et al. (2021) Dual use of artificial-intelligence-powered drug discovery. Nature Machine Intelligence, 4, 189–191.

  5. 5.

    See Kostal, M. E. (Ed.) (2020) Disruptive and Game Changing Technologies in Modern Warfare: Development, Use, and Proliferation. Springer Nature, Cham, Switzerland.

  6. 6.

    Dando, M. R. (1994) Biological Warfare in the 21st Century: Biotechnology and the Proliferation of Biological Weapons. Brassey’s, London. Chapter 4, Efforts to Control to 1991. p. 74.

  7. 7.

    Secretariat (1996) Background Paper on New Scientific and Technological Developments Relevant to the Convention on the Prohibition of the Development, Production and Stockpiling of Bacteriological (Biological) and Toxin Weapons and on their Destruction. BWC/CONF.IV/4*, United Nations, Geneva. 30 October. p. 11.

  8. 8.

    Dando, M. R. (2001) The New Biological Weapons: Threat, Proliferation and Control. Lynne Rienner, Boulder. Chapter 4, Toxins. pp. 45–66.

  9. 9.

    Petro, J. B. et al. (2003) Biotechnology: Impact on biological warfare and biodefense. Biosecurity and Bioterrorism, 1, 161–168. p. 162.

  10. 10.

    Nixdorff, K. (2020) Developments in systems biology: implications for health and biochemical security, The Nonproliferation Review, 27(4–6), 459–473.

  11. 11.

    McCellan, R. O. (2020) Critical Reviews of Toxicology: Celebrating 50 Years of Publishing Scientific Advances in Toxicology and Risk Analyses. Critical Reviews in Toxicology, 50(10), 827–835.

  12. 12.

    Choudhuri, S. et al. (2018) From Classical Toxicology to Tox21: Some Critical Conceptual and Technological Advances in the Molecular Understanding of the Toxic Response Beginning From the Last Quarter of the 20th Century. Toxicological Sciences, 161(1), 5–22. p. 5.

  13. 13.

    Middlebrook, J. L. and Franz, D. R. (1997) Botulinum Toxins, Chapter 33 in F.R. Sidell, et al. (Eds.) Medical Aspects of Chemical and Biological Warfare, Office of the Surgeon General, US Army, Washington, D.C. p. 647.

  14. 14.

    Janik, E. et al. (2019) Biological Toxins as the Potential Tools for Bioterrorism. International Journal of Molecular Sciences, 20, 1181: doi:10.3390/ijms20051181. pp. 3–5.

  15. 15.

    Pirazzini, M. et al. (2017) Botulinum Neurotoxin: Biology, Pharmacology, and Toxicity. Pharmacol Rev, 69, 200–235. p. 200.

  16. 16.

    Tehran, D. A. and Pirazzini, M. (2018) Novel Botulinum Neurotoxins: Exploring Underneath the Iceberg Tip. Toxins, 10, 190; doi:10.3390/toxins10050190. pp. 1, 9, 10.

  17. 17.

    Anandan, C. and Jankovic, J. (2021) Botulinum Toxin in Movement Disorders: An Update. Toxins, 13, 42; doi.org/10.3390/toxins13010042. p. 19.

  18. 18.

    Caleo, M. and Restani, L. (2018) Exploiting Botulinum Neurotoxins for the Study of Brain Physiology and Pathology. Toxins, 10, 175; doi:10.3390/toxins10050175.

  19. 19.

    Holford, M. and Rummel, A. (2018) An Interview with Cesare Montecucco. Toxins, 10, 307; doi:10.3390/toxins10080307. p. 5.

  20. 20.

    Huang, P-S. et al. (2016) The coming age of de novo protein design. Nature, 537, 320–327.

  21. 21.

    Jain, A. and Kihara, D. (2019) NNTox: Gene Ontology-Based Protein Toxicity Prediction Using Neural Network. Scientific Reports, 9, 17923; doi:10.1038/s41598-019-54405-6.

  22. 22.

    Horzmann, K. A. and Freeman, J. L. (2018) Making Waves: New Developments in Toxicology with the Zebrafish. Toxicological Sciences, 163(1), 5–12.

  23. 23.

    Pinchuk, I. V. et al. (2010) Staphylococcal Enterotoxins. Toxins, 2, 2177–2197; doi:10.3390/toxins2082177.

  24. 24.

    Pinchuk, I. V. et al. (2010), op. cit. pp. 2186–2187.

  25. 25.

    Regis, E. (1999) The Biology of Doom: The History of America’s Secret Germ Warfare Project. Henry Holt, New York. pp. 201–204.

  26. 26.

    Lindsay, C. D. and Griffiths, G. D. (2013) Addressing bioterrorism concerns: Options for investigating the mechanism of action of Staphylococcus aureus enterotoxin B. Human and Experimental Toxicology, 32(6), 606–619. pp. 606–607.

  27. 27.

    Berger, T. et al. (2016) Toxins as biological weapons for terror—characteristics, challenges and medical countermeasures: a mini review. Disaster and Military Medicine, 2(7); DOI 10.1186/s40696-016-0017-4. pp. 3–4.

  28. 28.

    Krakauer, T. (2019) Staphylococcal Superantigens: Pyrogenic Toxins Induce Toxic Shock. Toxins, 11, 178; doi:10.3390/toxins11030178. p. 2.

  29. 29.

    Krakauer, T. (2017) FDA-approved immunosuppressants targeting staphylococcal superantigens: mechanisms and insights. Immuno Targets and Therapy, 6, 17–29. pp. 17–18.

  30. 30.

    Horn, C. M. and Kielian, T. (2021) Crosstalk Between Staphylococcus aureus and Innate Immunity: Focus on Immunometabolism. Frontiers in Immunology, 11; doi:10.3389/fmmu.2020.621750.

  31. 31.

    World Health Organization (2004) Public Health Response to Biological and Chemical Weapons. 2ND edition, WHO, Geneva. p. 216.

  32. 32.

    Dando, M. R. (2006) The New Biological Weapons: Threat, Proliferation and Control. Lynne Rienner, Boulder, Colorado. See Chapter 5 Bioregulatory Peptides: ENDOTHELIN. pp. 68–73.

  33. 33.

    Koch, B. L. et al. (1999) Inhalation of Substance P and Thiorphan: Acute Toxicity and Effects on Respiration in Conscious Guinea Pigs. J. Appl. Toxicol., 19, 19–23. p. 22.

  34. 34.

    Hodo, T. W. et al. (2020) Critical Neurotransmitters in the Neuroimmune Network. Frontiers in Immunology, 11, Article 1869, doi:10.3389/fimmu.2020.01869. pp. 11–13.

  35. 35.

    Dando, M. R. (2020) Neuroscience and the Problem of Dual Use: Neuroethics in the New Brain Projects. Springer Nature, Switzerland. See Chapter 4 Dual Use Neuroscience. pp. 53–71.

  36. 36.

    World Health Organization (2021) Emerging technologies and dual-use concerns: a horizon scan for global public health. WHO, Geneva, October. p. 6.

  37. 37.

    World Health Organization (2021) op. cit. p. 8.

  38. 38.

    Greenberg, S. (undated) A Concise History of Immunology. Available at http://www.columbia.edu/itc/hs/medical/pathophys?immunology/readings/ConciseHistoryImmunology.pdf..

  39. 39.

    Nutma, E. et al. (2019) Neuroimmunology—the past, present and future. Clinical and Experimental Immunology, 197, 278–293;doi:10.1111/cel.13279.

  40. 40.

    Gruol, D. (2017) Advances in Neuroimmunology. Brain Sci, 7, 124; doi:10.3390/brainsci7100124. p. 1.

  41. 41.

    Caldwell, L. J. et al. (2020) Maximising the potential of neuroimmunology. Brain, Behavior and Immunity. https://doi.org/10.1016/j.bbi.2020.03.010. p. 2.

  42. 42.

    Couvineau, A. et al. (2019) Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases. Frontiers in Endocrinology, 10, Article 709; doi:10.3389/fendo.2019.00709.

  43. 43.

    Becquet, L. et al. (2019) Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminished neuroinflammation. Journal of Neuroinflammation, 16, 64. https://doi.org/10.1186/s12974-019-1447-y.

  44. 44.

    Nistico, R. et al. (2017) Synaptoimmunology—roles in health and disease. Molecular Brain, 10, 26; doi:10.1186/s13041-017-0308-9.

  45. 45.

    Collins, F. S. (2021) NIH launches new initiative to study “Long COVID.” Office of the NIH Director, Washington, D.C., 23 February.

  46. 46.

    Stefano, G. B. (2021) Historical Insights into Infections and Disorders Associated with Neurological and Psychiatric Sequelae Similar to Long COVID. Medical Science Monitor, 27, e931447; doi:10.12659/MSM.931447.

  47. 47.

    Harapan, B. N. and Yoo, H. J. (2021) Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). Journal of Neurology, https://doi.org/10.1007/s00415-021-10406-y. (p. 1).

  48. 48.

    Stevens, R. (2021) How does coronavirus affect the brain? John Hopkins Medicine Website. https://www.hopkinsmedicine.org/health.

  49. 49.

    Clark, G. C. et al. (2019) Friends or Foes? Emerging Impacts of Biological Toxins. Trends in the Biochemical Sciences. 44(4), 365–379. pp. 369, 376.

  50. 50.

    Snyder, S. H. (2018) The Brain Harbors Many Neurotransmitters, pp. 88–93 in D. J. Linden (Ed.) Think Tank: Forty Neuroscientists Explore the Biological Roots of Human Experience. Yale University Press, New Haven. p. 92.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael Crowley .

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Crowley, M., Dando, M.R. (2022). Dual-Use Chemical and Life Science Research of Potential Concern. In: Toxin and Bioregulator Weapons. Global Issues. Palgrave Macmillan, Cham. https://doi.org/10.1007/978-3-031-10164-9_2

Download citation

Publish with us

Policies and ethics

Navigation